Refining prognosis in non-small-cell lung cancer
Larsen, J.E.; Fong, K.M.; Hayward, N.K.
New England Journal of Medicine 356(2): 190; Author Reply 190-191
2007
ISSN/ISBN: 0028-4793 PMID: 17225285 Document Number: 614120
Document emailed within 1 workday
Related Documents
Huang, Z.Y.; Li, H.Z.; Xu, P.Q. 1988: Pathological findings and prognosis in 202 patients with small cell lung cancer Zhonghua Zhong Liu Za Zhi 10(1): 38-41Oomori, H.; Matsui, K.; Nakagawa, K.; Masuda, N.; Itoh, K.; Kudoh, S.; Takifuji, S.; Kusunoki, Y.; Takada, M.; Negoro, S. 1992: Prognosis of small cell lung cancer with ipsilateral pleural effusion Nihon Kyobu Shikkan Gakkai Zasshi 30(6): 1085-1090
Inoue, K.; Sagawa, M.; Sato, M.; Ono, S.; Matsumura, T.; Sakurada, A.; Handa, M.; Tanita, T.; Kondo, T.; Fujimura, S. 1998: Prognosis of T3 patients with resected non-small cell lung cancer according to the invaded organs Kyobu Geka. Japanese Journal of Thoracic Surgery 51(11): 907-910
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Kolesnik, A.P.; Shevchenko, A.I.; Tumanskiĭ, V.A.; Evseev, A.V. 2013: Effect of the intercellular adhesion molecule E-cadherin on the prognosis of non-small cell lung cancer Arkhiv Patologii 75(5): 30-33
Zhang, Z.; Guo, Y. 2014: High TBX2 expression predicts poor prognosis in non-small cell lung cancer Neoplasma 61(4): 476-480
Misthos, P.; Sepsas, E.; Kokotsakis, J.; Skottis, I.; Lioulias, A. 2009: Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling Journal of BUON: Official Journal of the Balkan Union of Oncology 14(1): 45-49
Hayakawa, K.; Mitsuhashi, N.; Saito, Y.; Takahashi, M.; Katano, S.; Shiojima, K.; Furuta, M.; Niibe, H. 1993: Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer Anticancer Research 13(5c): 1815-1820
Chen, W.-h.; Wang, C.; Zhang, Y.-h.; Yang, Y.-h.; Zhan, H.-y.; Zhang, L.-m. 2007: Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Zhonghua Yi Xue Za Zhi 87(45): 3228-3232
Sahin, C.; Omar, M.; Tunca, H.; Kalemci, S.; Ozseker, B.; Akbaba, G.; Tanriverdi, O. 2015: Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(6): 1576-1584
Liu, Y.-q.; Guo, R.-h.; Liu, L.-k.; Gao, W.; Zhu, C.-j.; Wei, J.; Shu, Y.-q. 2011: Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC) Zhonghua Zhong Liu Za Zhi 33(6): 426-430
Yang, B.; Zheng, D.; Zeng, Υa.; Qin, A.; Gao, J.; Yu, G. 2018: Circulating tumor cells predict prognosis following secondline AZD 9291 treatment in EGFR-T790M mutant non-small cell lung cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(4): 1077-1081
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Monnet, I.; Brienza, S.; Hugret, F.; Voisin, S.; Gastiaburu, J.; Saltiel, J.C.; Soulié, P.; Armand, J.P.; Cvitkovic, E.; de Cremoux, H. 1998: Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques European Journal of Cancer 34(7): 1124-1127
Xu, C.-a.; Su, H.; Liu, J.-l.; Li, L.; Zou, H.-w. 2011: Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor Zhonghua Zhong Liu Za Zhi 33(6): 436-441
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7